Want to see PRTCY full AI Analyst Report?
PureTech Health (PRTCY) Stock Statistics & Valuation Metrics
Total Valuation
PureTech Health has a market cap or net worth of $385.74M. The enterprise value is $243.44M.
- Market Cap
- $385.74M
- Enterprise Value
- $243.44M
Share Statistics
PureTech Health has 24,517,965 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 24,517,965
- Owned by Insiders
- ―
- Owned by Institutions
- 0.33%
Financial Efficiency
PureTech Health’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -19.67%.
- Return on Equity (ROE)
- -0.35
- Return on Assets (ROA)
- -0.21
- Return on Invested Capital (ROIC)
- -19.67%
- Return on Capital Employed (ROCE)
- -0.20
- Revenue Per Employee
- 51.77K
- Profits Per Employee
- -1.22M
- Employee Count
- 90
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PureTech Health is 160.04. PureTech Health’s PEG ratio is -0.23.
- PE Ratio
- 160.04
- PS Ratio
- 62.20
- PB Ratio
- 1.00
- Price to FCF
- -4.82
- Price to Operating Cash Flow
- -4.77
- PEG Ratio
- -0.23
Income Statement
In the last 12 months, PureTech Health had revenue of 4.66M and earned -109.74M in profits. Earnings per share was -46.00.
- Revenue
- 4.66M
- Gross Profit
- 4.66M
- Operating Income
- -98.53M
- Pretax Income
- -110.93M
- Net Income
- -109.74M
- EBITDA
- -61.80M
- Earnings Per Share (EPS)
- -46.00
Cash Flow
In the last 12 months, operating cash flow was -84.81M and capital expenditures -5,981, giving a free cash flow of -84.82M billion.
- Operating Cash Flow
- -84.81M
- Free Cash Flow
- -84.82M
- Free Cash Flow per Share
- -3.35
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.75%
- Earnings Yield
- 0.12%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -9.88%
- 50-Day Moving Average
- 15.65
- 200-Day Moving Average
- 16.70
- Relative Strength Index (RSI)
- 60.17
- Average Volume (3m)
- 30.97K
Important Dates
PureTech Health upcoming earnings date is Apr 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 22, 2026
- Next Earnings Date
- Apr 29, 2027
- Ex-Dividend Date
- ―
Financial Position
PureTech Health as a current ratio of 6.59, with Debt / Equity ratio of 6.33%
- Current Ratio
- 6.59
- Quick Ratio
- 6.59
- Debt to Market Cap
- 0.22
- Net Debt to EBITDA
- 3.79
- Interest Coverage Ratio
- -2.15
Taxes
In the past 12 months, PureTech Health has paid -842.00K in taxes.
- Income Tax
- -842.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
PureTech Health EV to EBITDA ratio is -2.91, with an EV/FCF ratio of -3.54.
- EV to Sales
- 45.65
- EV to EBITDA
- -2.91
- EV to Free Cash Flow
- -3.54
- EV to Operating Cash Flow
- -3.54
Balance Sheet
PureTech Health has $278.89M in cash and marketable securities with $19.76M in debt, giving a net cash position of $259.14M billion.
- Cash & Marketable Securities
- $278.89M
- Total Debt
- $19.76M
- Net Cash
- $259.14M
- Net Cash Per Share
- $10.57
- Tangible Book Value Per Share
- $126.40
Margins
Gross margin is 48.09%, with operating margin of -1618.58%, and net profit margin of 7.53%.
- Gross Margin
- 48.09%
- Operating Margin
- -1618.58%
- Pretax Margin
- 63.25%
- Net Profit Margin
- 7.53%
- EBITDA Margin
- -1566.67%
- EBIT Margin
- -1618.58%
Analyst Forecast
The average price target for PureTech Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -0.87%
- EPS Growth Forecast
- -95.55%
Scores
- Smart Score
- 2
- AI Score
- 50
